Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Non-Current Debt (2016 - 2026)

Cryo Cell International's Non-Current Debt history spans 17 years, with the latest figure at $875000.0 for Q1 2026.

  • Quarterly results put Non-Current Debt at $875000.0 for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Feb 2026 was $875000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $875000.0, down 89.47%.
  • Non-Current Debt for Q1 2026 was $875000.0 at Cryo Cell International, roughly flat from $875000.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $8.6 million in Q3 2022 to a low of $875000.0 in Q1 2022.
  • The 5-year median for Non-Current Debt is $875000.0 (2022), against an average of $3.5 million.
  • The sharpest move saw Non-Current Debt soared 883.91% in 2022, then tumbled 89.84% in 2023.
  • Year by year, Non-Current Debt stood at $8.6 million in 2022, then crashed by 89.8% to $875000.0 in 2023, then skyrocketed by 849.72% to $8.3 million in 2024, then tumbled by 89.47% to $875000.0 in 2025, then changed by 0.0% to $875000.0 in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $875000.0, $875000.0, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.